Evidence map›Paper›PMID 38260181›Full record

ArticleInfection and drug resistance2024

Combination of rRT-PCR and Clinical Features to Predict Coronavirus Disease 2019 for Nosocomial Infection Control.

Fumihiro Yamaguchi, Ayako Suzuki, Miyuki Hashiguchi, Emiko Kondo, Atsuo Maeda, Takuya Yokoe, Jun Sasaki, Yusuke Shikama, Munetaka Hayashi, Sei Kobayashi and 1 more

Open access · goldAbstract read
In one paragraph

Article in Infection and drug resistance, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Fumihiro YamaguchiDepartment of Respiratory Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.ORCID 0000-0003-1611-6991
Ayako SuzukiDepartment of Pharmacy, Showa University Fujigaoka Hospital, Yokohama, Japan.ORCID 0000-0001-6150-7700
Miyuki HashiguchiDepartment of Infection Control, Showa University Fujigaoka Hospital, Yokohama, Japan.
Emiko KondoDepartment of Infection Control, Showa University Fujigaoka Hospital, Yokohama, Japan.
Atsuo MaedaDepartment of Emergency and Critical Care Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.
Takuya YokoeDepartment of Respiratory Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.
Jun SasakiDepartment of Emergency and Critical Care Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.ORCID 0009-0003-6188-8568
Yusuke ShikamaDepartment of Respiratory Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.ORCID 0000-0003-3776-8366
Munetaka HayashiDepartment of Emergency and Critical Care Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan.
Sei KobayashiDepartment of Otolaryngology, Showa University Fujigaoka Hospital, Yokohama, Japan.
Hiroshi SuzukiDepartment of Cardiology, Showa University Fujigaoka Hospital, Yokohama, Japan.
Showa University Fujigaoka Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), immediately became a pandemic. Therefore, nosocomial infection control is necessary to screen for patients with possible COVID-19. Objective: This study aimed to investigate commonly measured clinical variables to predict COVID-19. Methods: This cross-sectional study enrolled 1087 patients in the isolation ward of a university hospital. Conferences were organized to differentiate COVID-19 from non-COVID-19 cases, and multiple nucleic acid tests were mandatory when COVID-19 could not be excluded. Multivariate logistic regression models were employed to determine the clinical factors associated with COVID-19 at the time of hospitalization. Results: Overall, 352 (32.4%) patients were diagnosed with COVID-19. The majority of the non-COVID-19 cases were predominantly caused by bacterial infections. Multivariate analysis indicated that COVID-19 was significantly associated with age, sex, body mass index, lactate dehydrogenase, C-reactive protein, and malignancy. Conclusion: Some clinical factors are useful to predict patients with COVID-19 among those with symptoms similar to COVID-19. This study suggests that at least two real-time reverse-transcription polymerase chain reactions of SARS-CoV-2 are recommended to exclude COVID-19.

Indexed as

coronavirus disease 2019cross sectional studyJapannosocomial infection controlnucleic acid testobesitysevere acute respiratory syndrome coronavirus-2

Identifiers

PMID38260181
PMCPMC10802122
OpenAlexW4390947574

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.